USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: MEDICASAFE, INC.
City: NEW YORK
State: NY
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $317,854.00 2
SBIR Phase II $993,194.00 1

Award List:

Real-time Adherence and Risk Management of Opioid Therapies

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $118,425.00
Abstract:
DESCRIPTION (provided by applicant): This application proposes the development of the Adherence and Risk Management of Opioids with Realtime Electronic Data (ARMORED) drug system. The system uses a low-cost, abuse-resistant drug dispensing device that cont rols access to opioid medications with… More

Real-time Adherence and Risk Management of Opioid Therapies

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Michael S. Davis – 978-631-1108
Award Amount: $993,194.00
Abstract:
DESCRIPTION (provided by applicant): Following a highly successful Phase I award, this Phase II SBIR application proposes development of MedicaSafe Opioids - a risk management system for the treatment of chronic pain patients prescribed opioid therapies. The need for this system arises from the… More

Enhanced treatment management of opioid-dependence in an office-based setting

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael S. Davis – 978-631-1108
Award Amount: $199,429.00
Abstract:
DESCRIPTION (provided by applicant): The abuse and misuse of opiods is already a significant healthcare problem that is expected to escalate dramatically in the next decade. Traditionally, the treatment of opioid-dependence has been provided in specialty care settings, such as residential… More